Rhythio Medical’s soft, conductive hydrogel technology transforms traditional defibrillation into a new class of injectable bioelectronic therapy Rhythio Medical, a medical device company pioneering ...
HOUSTON--(BUSINESS WIRE)--Rhythio Medical, a medical device company pioneering injectable bioelectronic therapies, today announced that its Injectable Electrode System has received Breakthrough Device ...
Rhythio Medical announced today that it received FDA breakthrough device designation for its Injectable Electrode System. The company’s proprietary offering aims to transform cardiac rhythm management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback